Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN

  • Elias Jabbour
  • , Nicholas J. Short
  • , Guillermo Montalban-Bravo
  • , Xuelin Huang
  • , Carlos Bueso-Ramos
  • , Wei Qiao
  • , Hui Yang
  • , Chong Zhao
  • , Tapan Kadia
  • , Gautam Borthakur
  • , Naveen Pemmaraju
  • , Koji Sasaki
  • , Zeev Estrov
  • , Jorge Cortes
  • , Farhad Ravandi
  • , Yesid Alvarado
  • , Rami Komrokji
  • , Mikkael A. Sekeres
  • , David P. Steensma
  • , Amy DeZern
    • Gail Roboz, Hagop Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

166   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology